CRMD vs. RIGL
CRMD (CorMedix Inc.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, CRMD returned 0.24%/yr vs 3.86%/yr for RIGL. Their 0.21 correlation means their historical movements had little consistent relationship.
Performance
CRMD vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRMD achieves a -35.25% return, which is significantly lower than RIGL's -14.06% return. Over the past 10 years, CRMD has underperformed RIGL with an annualized return of 0.24%, while RIGL has yielded a comparatively higher 3.86% annualized return.
CRMD
- 1D
- 0.53%
- 1M
- -11.10%
- 6M
- -2.96%
- YTD
- -35.25%
- 1Y
- -35.48%
- 3Y*
- 20.63%
- 5Y*
- 5.32%
- 10Y*
- 0.24%
- ALL TIME*
- -4.54%
RIGL
- 1D
- -3.28%
- 1M
- -3.87%
- 6M
- 5.59%
- YTD
- -14.06%
- 1Y
- 74.79%
- 3Y*
- 40.40%
- 5Y*
- -1.65%
- 10Y*
- 3.86%
- ALL TIME*
- -10.60%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CRMD CorMedix Inc. | $7.65M | $7.49M | $10.66M |
| $11.43M | $14.01M | $13.32M |
CRMD vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | -35.25% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 2.06% | 12.87% | 158.00% | -67.32% |
RIGL Rigel Pharmaceuticals, Inc. | -14.06% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between CRMD and RIGL is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.30 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.25 |
Correlation (All Time) Calculated using the full available price history since May 13, 2010 | 0.21 |
The correlation between CRMD and RIGL shifts across timeframes, from 0.13 (1 year) to 0.30 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CRMD:
$590.74M
RIGL:
$681.06M
CRMD:
$1.99
RIGL:
$18.94
CRMD:
3.79
RIGL:
1.94
CRMD:
1.71
RIGL:
2.36
CRMD:
1.60
RIGL:
1.81
CRMD:
$400.05M
RIGL:
$299.77M
CRMD:
$343.39M
RIGL:
$279.95M
CRMD:
$207.97M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRMD vs. RIGL — Risk / Return Rank
CRMD
RIGL
CRMD vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRMD | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.63 | ||
| Sortino ratioReturn per unit of downside risk | -2.42 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.25 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.62 | 1.50 | -2.12 |
| Martin ratioReturn relative to average drawdown | -0.90 | 2.51 | -3.42 |
Loading charts...
Drawdowns
CRMD vs. RIGL - Drawdown Comparison
The maximum CRMD drawdown since its inception was -98.28%, roughly equal to the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for CRMD and RIGL.
Loading charts...
Drawdown Indicators
| CRMD | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -99.37% | +1.09% |
Max Drawdown (1Y)Largest decline over 1 year | -57.86% | -50.08% | -7.78% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -50.76% | -11.50% |
Max Drawdown (5Y)Largest decline over 5 years | -62.63% | -83.85% | +21.22% |
Max Drawdown (10Y)Largest decline over 10 years | -94.77% | -86.40% | -8.37% |
Current DrawdownCurrent decline from peak | -84.74% | -96.55% | +11.81% |
Average DrawdownAverage peak-to-trough decline | -77.60% | -90.93% | +13.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.35% | 29.86% | +9.49% |
Volatility
CRMD vs. RIGL - Volatility Comparison
CorMedix Inc. (CRMD) has a higher volatility of 13.70% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 11.97%. This indicates that CRMD's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRMD | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.70% | 11.97% | +1.73% |
Volatility (6M)Calculated over the trailing 6-month period | 32.59% | 34.77% | -2.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 63.84% | 70.02% | -6.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.16% | 85.52% | -8.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.61% | 82.76% | +8.85% |
Dividends
CRMD vs. RIGL - Dividend Comparison
Neither CRMD nor RIGL has paid dividends to shareholders.
Financials
CRMD vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between CorMedix Inc. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRMD vs. RIGL - Profitability Comparison
CRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
CRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
CRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
CRMD and RIGL have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRMD has higher volatility (13.70%) compared to RIGL (11.97%). In terms of maximum drawdown, CRMD dropped -98.28% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (1.07 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRMD and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer